80 related articles for article (PubMed ID: 8485474)
1. Microbial carriage, sepsis, infection and acute GVHD in the first 25 BMT at the Royal Liverpool Children's Hospital.
Rhodes LE; van Saene HK; White S; Fairclough S; Ball LM; Martin J
Bone Marrow Transplant; 1993 Apr; 11(4):261-9. PubMed ID: 8485474
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of septicaemia on a paediatric oncology unit: a three-year experience at The Royal Liverpool Children's Hospital, Alder Hey, UK.
Paulus SC; van Saene HK; Hemsworth S; Hughes J; Ng A; Pizer BL
Eur J Cancer; 2005 Sep; 41(14):2132-40. PubMed ID: 16129600
[TBL] [Abstract][Full Text] [Related]
4. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
[TBL] [Abstract][Full Text] [Related]
5. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
6. Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.
Mitchell AE; Derrington P; Turner P; Hunt LP; Oakhill A; Marks DI
Bone Marrow Transplant; 2004 Feb; 33(3):303-10. PubMed ID: 14647252
[TBL] [Abstract][Full Text] [Related]
7. Prevention of infection in burns: preliminary experience with selective decontamination of the digestive tract in patients with extensive injuries.
Mackie DP; van Hertum WA; Schumburg T; Kuijper EC; Knape P
J Trauma; 1992 May; 32(5):570-5. PubMed ID: 1588644
[TBL] [Abstract][Full Text] [Related]
8. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT.
Kist-van Holthe JE; van Zwet JM; Brand R; van Weel MH; Vossen JM; van der Heijden AJ
Bone Marrow Transplant; 1998 Sep; 22(6):559-64. PubMed ID: 9758343
[TBL] [Abstract][Full Text] [Related]
10. [Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors].
Hamazaki T; Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Sasabe M; Kishimoto T; Inoue A; Kawa K
Rinsho Ketsueki; 2000 May; 41(5):430-6. PubMed ID: 10879106
[TBL] [Abstract][Full Text] [Related]
11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of gastrointestinal graft-versus-host disease--is rectal biopsy enough?
Nydegger A; Catto-Smith AG; Tiedemann K; Hardikar W
Pediatr Blood Cancer; 2007 May; 48(5):561-6. PubMed ID: 16862539
[TBL] [Abstract][Full Text] [Related]
13. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
15. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia.
Vicent MG; Madero L; Ortega JJ; Martinez A; Gomez P; Verdeguer A; Badell I; Muñoz A; Olive T; Maldonado MS; Bureo E; Cubells J; Diaz MA;
Bone Marrow Transplant; 2002 Jul; 30(1):9-13. PubMed ID: 12105771
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.
Martin P; Bleyzac N; Souillet G; Galambrun C; Bertrand Y; Maire PH; Jelliffe RW; Aulagner G
Bone Marrow Transplant; 2003 Nov; 32(9):881-7. PubMed ID: 14561988
[TBL] [Abstract][Full Text] [Related]
17. Long-term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients.
Leone M; Albanese J; Antonini F; Nguyen-Michel A; Martin C
Crit Care Med; 2003 Aug; 31(8):2090-5. PubMed ID: 12973164
[TBL] [Abstract][Full Text] [Related]
18. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
[TBL] [Abstract][Full Text] [Related]
19. Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT.
Belanger C; Esperou-Bourdeau H; Bordigoni P; Jouet JP; Souillet G; Milpied N; Troussard X; Kuentz M; Herve P; Reiffers J
Bone Marrow Transplant; 1993 Apr; 11(4):293-7. PubMed ID: 8485477
[TBL] [Abstract][Full Text] [Related]
20. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S
Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]